Shares of RTI Surgical Inc (NASDAQ:RTIX) have been assigned a consensus broker rating score of 3.00 (Hold) from the one analysts that cover the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a hold rating.

Analysts have set a twelve-month consensus target price of $5.00 for the company and are expecting that the company will post $0.02 earnings per share for the current quarter, according to Zacks. Zacks has also given RTI Surgical an industry rank of 80 out of 255 based on the ratings given to related companies.

Several analysts have commented on RTIX shares. ValuEngine raised shares of RTI Surgical from a “hold” rating to a “buy” rating in a research report on Monday, July 2nd. Zacks Investment Research raised shares of RTI Surgical from a “hold” rating to a “buy” rating and set a $5.25 target price for the company in a research report on Tuesday, August 7th. Finally, BidaskClub raised shares of RTI Surgical from a “sell” rating to a “hold” rating in a research report on Tuesday, July 3rd.

RTI Surgical stock traded up $0.01 during trading hours on Friday, hitting $4.75. The company had a trading volume of 2,807 shares, compared to its average volume of 126,182. The firm has a market cap of $285.20 million, a PE ratio of 95.00 and a beta of 1.40. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.55 and a current ratio of 3.86. RTI Surgical has a fifty-two week low of $3.85 and a fifty-two week high of $5.10.

RTI Surgical (NASDAQ:RTIX) last released its quarterly earnings data on Thursday, August 2nd. The medical equipment provider reported $0.03 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.01 by $0.02. The firm had revenue of $70.69 million for the quarter, compared to analyst estimates of $70.09 million. RTI Surgical had a net margin of 1.23% and a return on equity of 3.04%. Equities analysts anticipate that RTI Surgical will post 0.11 EPS for the current fiscal year.

Hedge funds have recently bought and sold shares of the business. Citadel Advisors LLC bought a new stake in RTI Surgical in the first quarter worth approximately $130,000. MetLife Investment Advisors LLC grew its position in RTI Surgical by 245.9% in the first quarter. MetLife Investment Advisors LLC now owns 28,338 shares of the medical equipment provider’s stock worth $130,000 after acquiring an additional 20,146 shares in the last quarter. JPMorgan Chase & Co. grew its position in RTI Surgical by 204.0% in the first quarter. JPMorgan Chase & Co. now owns 44,163 shares of the medical equipment provider’s stock worth $204,000 after acquiring an additional 29,634 shares in the last quarter. ClariVest Asset Management LLC grew its position in RTI Surgical by 20.4% in the second quarter. ClariVest Asset Management LLC now owns 67,697 shares of the medical equipment provider’s stock worth $311,000 after acquiring an additional 11,486 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. grew its position in RTI Surgical by 16.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 125,900 shares of the medical equipment provider’s stock worth $580,000 after acquiring an additional 17,600 shares in the last quarter. 68.72% of the stock is owned by institutional investors.

About RTI Surgical

RTI Surgical, Inc, together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.

See Also: 52-Week High/Low

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.